MS: Cytokine Fails to Gauge Tx Response

Serum
levels of interleukin 17F (IL-17F) were not associated with the response to
treatment with interferon beta-1b in patients with relapsing-remitting multiple
sclerosis, researchers found.

There were no significant differences in IL-17F concentrations when comparing
patients with less versus more disease activity, those with no versus some
disease activity, or clinically-defined responders versus nonresponders,
according to Hans-Peter Hartung, MD, of Heinrich-Heine-Universität in Düsseldorf,
Germany, and colleagues. 


FULL STORY»

Information provided by:

Cherie
C. Binns RN BS MSCN